|
US6140466A
(en)
|
1994-01-18 |
2000-10-31 |
The Scripps Research Institute |
Zinc finger protein derivatives and methods therefor
|
|
WO1996002561A1
(en)
*
|
1994-07-20 |
1996-02-01 |
The General Hospital Corporation |
Interaction trap systems for detecting protein interactions
|
|
ATE524545T1
(de)
|
1994-08-20 |
2011-09-15 |
Gendaq Ltd |
Verbesserungen bei oder im zusammenhang mit bindeproteinen zur erkennung von dna
|
|
GB9824544D0
(en)
|
1998-11-09 |
1999-01-06 |
Medical Res Council |
Screening system
|
|
US20050002902A1
(en)
*
|
1995-12-28 |
2005-01-06 |
Liming Yu |
Hybrid with interferon-alpha and an immunoglobulin Fc for treatment of tumors and viral infections
|
|
US6365344B1
(en)
*
|
1996-01-23 |
2002-04-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for screening for transdominant effector peptides and RNA molecules
|
|
DE69722176T2
(de)
|
1996-01-23 |
2004-03-18 |
The Board Of Trustees Of The Leland Stanford Junior University, Palo Alto |
Verfahren zur suche nach transdominanten effektorpeptiden und rna-molekülen
|
|
US5955275A
(en)
|
1997-02-14 |
1999-09-21 |
Arcaris, Inc. |
Methods for identifying nucleic acid sequences encoding agents that affect cellular phenotypes
|
|
US6060240A
(en)
*
|
1996-12-13 |
2000-05-09 |
Arcaris, Inc. |
Methods for measuring relative amounts of nucleic acids in a complex mixture and retrieval of specific sequences therefrom
|
|
US6623922B1
(en)
|
1997-02-14 |
2003-09-23 |
Deltagen Proteomics |
Methods for identifying, characterizing, and evolving cell-type specific CIS regulatory elements
|
|
GB9710809D0
(en)
|
1997-05-23 |
1997-07-23 |
Medical Res Council |
Nucleic acid binding proteins
|
|
US6969584B2
(en)
*
|
1997-06-12 |
2005-11-29 |
Rigel Pharmaceuticals, Inc. |
Combinatorial enzymatic complexes
|
|
DE19737562A1
(de)
*
|
1997-08-28 |
1999-05-06 |
Otogene Biotechnologische Fors |
Verfahren zur Identifizierung von Wechselwirkungen zwischen Proteinen bzw. Peptiden
|
|
AU1582799A
(en)
*
|
1997-11-07 |
1999-05-31 |
Iconix Pharmaceuticals, Inc. |
Surrogate genetics target characterization method
|
|
US6197502B1
(en)
*
|
1997-11-17 |
2001-03-06 |
Cytos Biotechnology Ag |
Expression cloning processes for the discovery characterization, and isolation of genes encoding polypeptides with a predetermined property
|
|
US6475726B1
(en)
|
1998-01-09 |
2002-11-05 |
Cubist Pharmaceuticals, Inc. |
Method for identifying validated target and assay combinations for drug development
|
|
US6846625B1
(en)
|
1998-01-09 |
2005-01-25 |
Cubist Pharmaceuticals, Inc. |
Method for identifying validated target and assay combination for drug development
|
|
US6410248B1
(en)
|
1998-01-30 |
2002-06-25 |
Massachusetts Institute Of Technology |
General strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites
|
|
DE19805334A1
(de)
*
|
1998-02-11 |
1999-08-12 |
Otogene Biotechnologische Fors |
Verfahren zur Entwicklung eines pharmazeutischen Wirkstoffes
|
|
CA2319112C
(en)
*
|
1998-02-13 |
2003-10-28 |
Genetrace Systems, Inc. |
Use of ribozymes for functionating genes
|
|
DE69942334D1
(de)
|
1998-03-02 |
2010-06-17 |
Massachusetts Inst Technology |
Poly-zinkfinger-proteine mit verbesserten linkern
|
|
WO1999047656A2
(en)
|
1998-03-17 |
1999-09-23 |
Gendaq Limited |
Nucleic acid binding proteins
|
|
WO1999053031A2
(en)
*
|
1998-04-08 |
1999-10-21 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Process for producing cell clone libraries
|
|
CA2327830A1
(en)
*
|
1998-04-09 |
1999-10-21 |
Iconix Pharmaceuticals Inc. |
Methods for identifying genetic determinants associated with modulation of test compound activity
|
|
US6897031B1
(en)
*
|
1998-04-17 |
2005-05-24 |
Rigel Pharmaceuticals, Inc. |
Multiparameter FACS assays to detect alterations in exocytosis
|
|
US8334238B2
(en)
*
|
1998-04-17 |
2012-12-18 |
Rigel, Inc. |
Multiparameter FACS assays to detect alterations in cellular parameters and to screen small molecule libraries
|
|
US6461813B2
(en)
*
|
1998-09-21 |
2002-10-08 |
Rigel Pharmaceuticals, Inc. |
Multiparameter FACS assays to detect alterations in cell cycle regulation
|
|
US7090976B2
(en)
*
|
1999-11-10 |
2006-08-15 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions comprising Renilla GFP
|
|
US20040002056A1
(en)
*
|
1998-05-12 |
2004-01-01 |
Lorens James B. |
Methods of screening for bioactive agents using cells transformed with self-inactivating viral vectors
|
|
US7001733B1
(en)
*
|
1998-05-12 |
2006-02-21 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions for screening for modulations of IgE synthesis, secretion and switch rearrangement
|
|
US7060433B1
(en)
*
|
1999-11-12 |
2006-06-13 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions for screening using diphtheria toxin constructs
|
|
US6413776B1
(en)
|
1998-06-12 |
2002-07-02 |
Galapagos Geonomics N.V. |
High throughput screening of gene function using adenoviral libraries for functional genomics applications
|
|
DE19829495A1
(de)
*
|
1998-07-02 |
2000-01-05 |
Jacques Paysan |
Reagenzien und deren Anwendung zur Untersuchung von Wechselwirkungen zwischen zellulären Molekülen und deren Lokalisation in Zellen
|
|
EP1098991B1
(en)
*
|
1998-07-20 |
2002-09-11 |
Inoxell A/S |
Novel methods for the identification of ligand and target biomolecules
|
|
EP1270746A1
(en)
*
|
1998-07-20 |
2003-01-02 |
Inoxell A/S |
Methods for the identification of ligand and target biomolecules
|
|
US6472151B1
(en)
*
|
1998-08-19 |
2002-10-29 |
Bristol-Myers Squibb Company |
Method of screening for compounds that modulate the activity of a molecular target
|
|
WO2000020859A1
(en)
*
|
1998-10-05 |
2000-04-13 |
Duke University |
METHOD AND APPARATUS FOR DETECTING BINDING INTERACTIONS $i(IN VIVO)
|
|
US6599692B1
(en)
|
1999-09-14 |
2003-07-29 |
Sangamo Bioscience, Inc. |
Functional genomics using zinc finger proteins
|
|
US6453242B1
(en)
|
1999-01-12 |
2002-09-17 |
Sangamo Biosciences, Inc. |
Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
|
|
US7013219B2
(en)
|
1999-01-12 |
2006-03-14 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
|
US7070934B2
(en)
|
1999-01-12 |
2006-07-04 |
Sangamo Biosciences, Inc. |
Ligand-controlled regulation of endogenous gene expression
|
|
US6534261B1
(en)
|
1999-01-12 |
2003-03-18 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
|
US6720139B1
(en)
|
1999-01-27 |
2004-04-13 |
Elitra Pharmaceuticals, Inc. |
Genes identified as required for proliferation in Escherichia coli
|
|
WO2000053743A1
(en)
*
|
1999-03-12 |
2000-09-14 |
Gpc Biotech, Inc. |
Methods and reagents for identifying synthetic genetic elements
|
|
JP2002538842A
(ja)
*
|
1999-03-16 |
2002-11-19 |
デイナ−ファーバー キャンサー インスティチュート，インコーポレイテッド |
大量のスクリーニングのためのレンチウイルスベクター系
|
|
US7030215B2
(en)
|
1999-03-24 |
2006-04-18 |
Sangamo Biosciences, Inc. |
Position dependent recognition of GNN nucleotide triplets by zinc fingers
|
|
US6794136B1
(en)
|
2000-11-20 |
2004-09-21 |
Sangamo Biosciences, Inc. |
Iterative optimization in the design of binding proteins
|
|
US20030104526A1
(en)
|
1999-03-24 |
2003-06-05 |
Qiang Liu |
Position dependent recognition of GNN nucleotide triplets by zinc fingers
|
|
EP1041144B1
(en)
*
|
1999-03-29 |
2004-06-23 |
Michael Blind |
Methods for the identification and validation of functional intracellular targets with intramers or in vivo selection
|
|
US6524797B1
(en)
|
1999-05-10 |
2003-02-25 |
Bernhard O. Palsson |
Methods of identifying therapeutic compounds in a genetically defined setting
|
|
AU5303200A
(en)
*
|
1999-05-25 |
2000-12-12 |
Rigel Pharmaceuticals, Inc. |
Identification of novel mechanisms of drug resistance
|
|
US6737240B1
(en)
|
1999-05-25 |
2004-05-18 |
Rigel Pharmaceuticals, Inc. |
Methods of screening for a multi-drug resistance conferring peptide
|
|
EP1055929A1
(en)
|
1999-05-26 |
2000-11-29 |
Tibotec N.V. |
Means and methods for drug discovery and the phenotypic characterisation of cells
|
|
AU2005209649B2
(en)
*
|
1999-05-31 |
2008-05-29 |
Novozymes A/S |
Screening method for peptides
|
|
JP2003509010A
(ja)
*
|
1999-05-31 |
2003-03-11 |
ノボザイムス アクティーゼルスカブ |
ペプチドのスクリーニング方法
|
|
WO2001034810A2
(en)
|
1999-11-09 |
2001-05-17 |
Elitra Pharmaceuticals, Inc. |
Genes essential for microbial proliferation
|
|
DK1228233T3
(da)
*
|
1999-11-10 |
2007-05-14 |
Rigel Pharmaceuticals Inc |
Fremgangsmåder og sammensætninger omfattende grönfluorescerende proteiner (GFP) fra Renilla
|
|
CA2394850C
(en)
|
1999-12-06 |
2012-02-07 |
Sangamo Biosciences, Inc. |
Methods of using randomized libraries of zinc finger proteins for the identification of gene function
|
|
EP2392596A3
(en)
*
|
1999-12-28 |
2013-11-27 |
ESBATech, an Alcon Biomedical Research Unit LLC |
Intrabodies with defined framework that is stable in a reducing environment and applications thereof
|
|
WO2001053480A1
(en)
|
2000-01-24 |
2001-07-26 |
Sangamo Biosciences, Inc. |
Nucleic acid binding polypeptides characterized by flexible linkers connected nucleic acid binding modules
|
|
US6582899B1
(en)
*
|
2000-02-15 |
2003-06-24 |
Deltagen Proteomics, Inc. |
Methods for identifying agents that cause a lethal phenotype, and agents thereof
|
|
US7566765B2
(en)
*
|
2000-03-06 |
2009-07-28 |
Rigel Pharmaceuticals, Inc. |
Heterocyclic compounds containing a nine-membered carbon-nitrogen ring
|
|
US7378248B2
(en)
*
|
2000-03-06 |
2008-05-27 |
Rigel Pharmaceuticals, Inc. |
In vivo production of cyclic peptides for inhibiting protein-protein interaction
|
|
US7252952B2
(en)
*
|
2000-03-06 |
2007-08-07 |
Rigel Pharmaceuticals, Inc. |
In vivo production of cyclic peptides for inhibiting protein—protein interaction
|
|
AU2001247296A1
(en)
*
|
2000-03-06 |
2001-09-17 |
Rigel Pharmaceuticals, Inc. |
In vivo production of cyclic peptides
|
|
WO2001075178A2
(en)
*
|
2000-04-04 |
2001-10-11 |
Enanta Pharmaceuticals, Inc. |
Methods for identifying peptide aptamers capable of altering a cell phenotype
|
|
US6762031B2
(en)
*
|
2000-06-16 |
2004-07-13 |
University Of Medicine And Dentistry Of New Jersey |
Targeting viral vectors to specific cells
|
|
US20030148924A1
(en)
*
|
2002-07-09 |
2003-08-07 |
Tamar Tennenbaum |
Methods and pharmaceutical compositions of healing wounds
|
|
WO2002009639A2
(en)
*
|
2000-07-31 |
2002-02-07 |
Bar Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
|
US20100129332A1
(en)
*
|
2000-07-31 |
2010-05-27 |
Tamar Tennenbaum |
Methods and pharmaceutical compositions for healing wounds
|
|
US20040037828A1
(en)
*
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
|
US20060258562A1
(en)
*
|
2000-07-31 |
2006-11-16 |
Healor Ltd. |
Methods and pharmaceutical compositions for healing wounds
|
|
DE10060959A1
(de)
*
|
2000-12-06 |
2002-06-20 |
Aventis Res & Tech Gmbh & Co |
Verfahren zur Isolierung und Identifizierung von Effektoren
|
|
US7067317B2
(en)
|
2000-12-07 |
2006-06-27 |
Sangamo Biosciences, Inc. |
Regulation of angiogenesis with zinc finger proteins
|
|
AU2002228841C1
(en)
|
2000-12-07 |
2006-11-23 |
Sangamo Biosciences, Inc |
Regulation of angiogenesis with zinc finger proteins
|
|
US7700274B2
(en)
|
2000-12-22 |
2010-04-20 |
Sagres Discovery, Inc. |
Compositions and methods in cancer associated with altered expression of KCNJ9
|
|
US7645441B2
(en)
|
2000-12-22 |
2010-01-12 |
Sagres Discovery Inc. |
Compositions and methods in cancer associated with altered expression of PRLR
|
|
US7892730B2
(en)
|
2000-12-22 |
2011-02-22 |
Sagres Discovery, Inc. |
Compositions and methods for cancer
|
|
US7820447B2
(en)
|
2000-12-22 |
2010-10-26 |
Sagres Discovery Inc. |
Compositions and methods for cancer
|
|
WO2002057294A2
(en)
|
2001-01-22 |
2002-07-25 |
Sangamo Biosciences, Inc. |
Zinc finger proteins for dna binding and gene regulation in plants
|
|
US20030104402A1
(en)
*
|
2001-01-23 |
2003-06-05 |
University Of Rochester |
Methods of producing or identifying intrabodies in eukaryotic cells
|
|
US20020192675A1
(en)
*
|
2001-02-02 |
2002-12-19 |
The University Of Rochester |
Methods of identifying regulator molecules
|
|
JP2004530117A
(ja)
*
|
2001-02-22 |
2004-09-30 |
プラエシス ファーマシューティカルズ インコーポレーテッド |
生物プロセスを調節するペプチドを同定する方法
|
|
IL142481A0
(en)
*
|
2001-04-05 |
2002-03-10 |
Yissum Res Dev Co |
A method for identifying consitutively active mutants of mitogen activated protein kinases (mapk) and uses thereof
|
|
DE10119999A1
(de)
*
|
2001-04-23 |
2002-10-24 |
Univ Heidelberg |
Verfahren zur Identifizierung und Entwicklung von Substanzen oder Substanzgemischen die zelluläre Transport-, Prozessierungs- und Sekretionsprozesse beeinflussen
|
|
US20050255464A1
(en)
*
|
2001-07-19 |
2005-11-17 |
Hagen Frederick S |
Methods for the identification of peptidyl compounds interacting with extracellular target molecules
|
|
GB0118532D0
(en)
*
|
2001-07-30 |
2001-09-19 |
Isis Innovation |
Materials and methods relating to improved vaccination strategies
|
|
WO2003031573A2
(en)
*
|
2001-10-05 |
2003-04-17 |
Coley Pharmaceutical Gmbh |
Toll-like receptor 3 signaling agonists and antagonists
|
|
AU2002353997A1
(en)
*
|
2001-11-01 |
2003-05-12 |
Rensselaer Polytechnic Institute |
In vitro metabolic engineering on microscale devices
|
|
WO2003040168A2
(en)
*
|
2001-11-06 |
2003-05-15 |
Enanta Pharmaceuticals, Inc. |
Methods and compositions for identifying peptide aptamers capable of altering a cell phenotype
|
|
US7262054B2
(en)
|
2002-01-22 |
2007-08-28 |
Sangamo Biosciences, Inc. |
Zinc finger proteins for DNA binding and gene regulation in plants
|
|
WO2003062420A1
(en)
*
|
2002-01-23 |
2003-07-31 |
Gardner, Rebecca, Katherine |
Molecular libraries
|
|
EP1501855A4
(en)
|
2002-03-21 |
2006-02-22 |
Sagres Discovery Inc |
NEW COMPOSITIONS AND METHODS FOR CANCER
|
|
US20030219723A1
(en)
*
|
2002-05-20 |
2003-11-27 |
Lu Henry H. |
Compositions and methods for screening and identifying anti-HCV agents
|
|
WO2003104455A1
(en)
*
|
2002-06-07 |
2003-12-18 |
Sophion Bioscience A/S |
Screening methods
|
|
WO2004001044A1
(en)
*
|
2002-06-21 |
2003-12-31 |
Sinogenomax Company Ltd. |
Randomised dna libraries and double-stranded rna libraries, use and method of production thereof
|
|
US7361635B2
(en)
|
2002-08-29 |
2008-04-22 |
Sangamo Biosciences, Inc. |
Simultaneous modulation of multiple genes
|
|
AU2003269851A1
(en)
*
|
2002-10-09 |
2004-05-04 |
Novozymes A/S |
A method for screening for an antimicrobial polypeptide
|
|
US20070099185A1
(en)
*
|
2002-11-04 |
2007-05-03 |
Bioarctic Neuroscience Ab |
Methods for the identification of agents that modulate the structure and processing of beta-amyloid precursor protein
|
|
JP2006505271A
(ja)
*
|
2002-11-04 |
2006-02-16 |
アイコジェネックス コーポレイション |
膜結合前駆タンパク質の構造およびプロセシングを調節する物質の同定のための方法
|
|
EP1592708A2
(en)
|
2003-02-14 |
2005-11-09 |
Sagres Discovery, Inc. |
Therapeutic gpcr targets in cancer
|
|
AU2004231997A1
(en)
*
|
2003-04-16 |
2004-11-04 |
The University Of Mississippi |
Immunostimulatory agents in botanicals
|
|
WO2004094992A2
(en)
*
|
2003-04-23 |
2004-11-04 |
Bioseek, Inc. |
Methods for analysis of biological dataset profiles
|
|
GB0313173D0
(en)
*
|
2003-06-07 |
2003-07-16 |
Givaudan Sa |
Improvements in or related to organic compounds
|
|
NZ588743A
(en)
*
|
2003-07-15 |
2012-05-25 |
Univ Bar Ilan |
Use of a protein kinase C (PKC) alpha inhibitor for treating inflammation of the skin
|
|
US7776584B2
(en)
*
|
2003-08-01 |
2010-08-17 |
Genetix Limited |
Animal cell colony picking apparatus and method
|
|
WO2005013885A2
(en)
*
|
2003-08-07 |
2005-02-17 |
Healor Ltd. |
Pharmaceutical compositions and methods for accelerating wound healing
|
|
US20050052687A1
(en)
*
|
2003-08-12 |
2005-03-10 |
Murata Kikai Kabushiki Kaisha |
Image processing device and communication terminal device
|
|
CA2560751A1
(en)
*
|
2004-03-22 |
2005-10-06 |
The Ohio State University Research Foundation |
Methods for transfecting natural killer cells
|
|
US7745196B1
(en)
|
2004-03-25 |
2010-06-29 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions for identifying peptide modulators of cell surface receptors
|
|
WO2005115433A2
(en)
*
|
2004-05-24 |
2005-12-08 |
Rigel Pharmaceuticals, Inc. |
Methods for cyclizing synthetic polymers
|
|
AU2005250055B2
(en)
|
2004-06-02 |
2008-09-11 |
Adalta Pty Ltd |
Binding moieties based on shark IgNAR domains
|
|
WO2006039630A2
(en)
*
|
2004-10-02 |
2006-04-13 |
Indiana University Research & Technology Corporation |
Materials and methods for identifying compounds that modulate the cell cycle
|
|
CA2603093A1
(en)
|
2005-03-31 |
2006-10-05 |
Agensys, Inc. |
Antibodies and related molecules that bind to 161p2f10b proteins
|
|
AU2006235276A1
(en)
|
2005-04-07 |
2006-10-19 |
Novartis Vaccines And Diagnostics Inc. |
CACNA1E in cancer diagnosis, detection and treatment
|
|
EP1871911A2
(en)
|
2005-04-07 |
2008-01-02 |
Chiron Corporation |
Cancer-related genes (prlr)
|
|
EP2462944A3
(en)
*
|
2005-08-29 |
2012-09-12 |
HealOr Ltd. |
Methods and compositions for prevention and treatment of diabetic and aged skin
|
|
CA2628219C
(en)
*
|
2005-11-01 |
2012-11-27 |
Rensselaer Polytechnic Institute |
Three-dimensional cellular array chip and platform for toxicology assays
|
|
US8242057B2
(en)
*
|
2006-06-26 |
2012-08-14 |
Cleveland Biolabs, Inc. |
Methods for identifying modulators of apoptosis
|
|
CN102755649A
(zh)
*
|
2007-07-30 |
2012-10-31 |
希尔洛有限公司 |
药物组合物及相关方法
|
|
CN102325789A
(zh)
*
|
2009-02-24 |
2012-01-18 |
希尔洛有限公司 |
用于治疗痤疮和其它病症的内脂素治疗药物
|
|
EP2424986A1
(en)
*
|
2009-04-27 |
2012-03-07 |
Roswell Park Cancer Institute |
Reagents and methods for producing bioactive secreted peptides
|
|
CA2763493A1
(en)
*
|
2009-05-28 |
2010-12-02 |
Glaxo Group Ltd. |
Antigen-binding proteins
|
|
JP2013516500A
(ja)
|
2010-01-11 |
2013-05-13 |
ヒールオア・リミテッド |
炎症性疾患および障害を治療するための方法
|
|
WO2013016220A1
(en)
|
2011-07-22 |
2013-01-31 |
Amgen Inc. |
Il-17 receptor a is required for il-17c biology
|
|
EP2773743B1
(en)
|
2011-11-04 |
2019-05-22 |
Bio-Rad Laboratories, Inc. |
Affinity methods and compositions employing electronic control of ph
|
|
GB2523211B
(en)
|
2012-01-27 |
2020-03-18 |
Univ Jefferson |
MCT protein inhibitor-related prognostic and therapeutic methods
|
|
EP2812349B1
(en)
|
2012-02-10 |
2021-09-01 |
Cambridge Enterprise Limited |
Methods for the characterisation of interaction sites on target proteins
|
|
CN104540518A
(zh)
|
2012-04-27 |
2015-04-22 |
西托姆克斯治疗公司 |
结合表皮生长因子受体的可活化的抗体其使用方法
|
|
GB2505237A
(en)
*
|
2012-08-24 |
2014-02-26 |
Stefan Grimm |
Method of screening for therapeutic agents using cell lines including a reference cell line
|
|
WO2014172627A1
(en)
|
2013-04-19 |
2014-10-23 |
Thomas Jefferson University |
Caveolin-1 related methods for treating glioblastoma with temozolomide
|
|
WO2015066279A2
(en)
|
2013-10-30 |
2015-05-07 |
Cytomx Therapeutics, Inc. |
Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
|
|
US9737623B2
(en)
|
2013-12-11 |
2017-08-22 |
Cytomx Therapeutics, Inc. |
Antibodies that bind activatable antibodies and methods of use thereof
|
|
US10208099B2
(en)
*
|
2015-06-11 |
2019-02-19 |
Genexine, Inc. |
Modified interleukin-7 protein
|
|
US10519207B2
(en)
|
2015-06-12 |
2019-12-31 |
Georgia State University Research Foundation, Inc. |
Compositions and methods for treating opioid tolerance
|
|
KR102386735B1
(ko)
|
2015-11-06 |
2022-04-14 |
주식회사 제넥신 |
변형된 인터루킨-7 융합 단백질의 제형
|
|
WO2017095140A1
(ko)
|
2015-12-04 |
2017-06-08 |
주식회사 제넥신 |
면역글로불린 fc가 융합된 인터루킨-7 융합 단백질을 포함하는 인플루엔자 바이러스 감염의 예방 또는 치료용 약학적 조성물
|
|
WO2017095191A1
(ko)
|
2015-12-04 |
2017-06-08 |
주식회사 제넥신 |
면역글로불린 fc가 융합된 인터루킨-7 융합 단백질을 포함하는 사람 파필로마바이러스 유래 질환의 예방 또는 치료용 약학적 조성물
|
|
WO2022159936A1
(en)
*
|
2021-01-19 |
2022-07-28 |
Hope Patents, Llc |
A method for identifying peptide therapeutics to treat a variety of conditions
|